LAUREN MULLINS: Open Payments
NPI 1376285700 · LAKEWOOD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,949 in 90 payments from 13 companies in 2025. Trend: 2023 $2,637 · 2024 $1,670 · 2025 $1,949
Food & beverage: $1,799Education: $150
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $552 |
| ABBVIE INC. | 20 | $417 |
| Regeneron Healthcare Solutions, Inc. | 5 | $209 |
| Novartis Pharmaceuticals Corporation | 11 | $149 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $135 |
| GENZYME CORPORATION | 4 | $128 |
| UCB, Inc. | 4 | $87 |
| Galderma Laboratories, L.P. | 4 | $86 |
| Lilly USA, LLC | 3 | $71 |
| Arcutis Biotherapeutics, Inc. | 4 | $66 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, RINVOQ, ILUMYA, Bimzelx, NEMLUVIO, TALTZ.
Industry payments across WA — which companies pay providers there.
